Skip to main content
. 2022 Jun 20;9:907313. doi: 10.3389/fvets.2022.907313

Figure 2.

Figure 2

A histogram displaying initial phenobarbital dose reported by the 206 respondents who selected phenobarbital as their preferred first line antiseizure drug for canine idiopathic epilepsy.